Literature DB >> 10232657

Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.

M C Charlesworth1, C Y Young, V M Miller, D J Tindall.   

Abstract

Prostate-specific human glandular kallikrein (hK2) is an active enzyme in human seminal fluid. It is one of three serine proteases in the human kallikrein gene family, which includes hK1 (tissue kallikrein) and hK3 (prostate-specific antigen [PSA]). In order to examine kininogenase activity (i.e., production of kinin by these enzymes), we tested for bradykinin and/or Lys-bradykinin release upon incubation of hK2 and for other kallikreins with high-molecular weight kininogen (HMWK), which contains the nonapeptide bradykinin. Kinins are important regulatory peptides (especially for vascular permeability), and they may have a role in enhancing sperm motility. High-molecular weight kininogen is the substrate for plasma kallikrein (PKa potent kinin-generating enzyme circulating in blood, not of the same gene family) and for hK1. Glandular kallikrein and protein-C inhibitor (PCI)-hK2 complex, a serpin protease inhibitor that binds hK2, were purified to homogeneity by affinity and size-exclusion chromatography. About one-half of the hK2 is found in complex with PCI. The kallikrein enzymes were incubated with HMWK, and the resulting cleavage products were analyzed for kinin activity using enzyme immunoassay, high-performance liquid chromatography and mass spectrometry, and in vitro bioassay. Our results show that hK2 cleaves HMWK to produce bradykinin, not Lys-bradykinin (like hK1), and the resultant heavy (56-kDa) and light (42-kDa) chains of HMWK show similar electrophoretic mobility to those cleaved by PK. Prostate-specific antigen (hK3) had no kinin-generating activity. We also identified three other internal cleavage sites for hK2 in HMWK (Arg427, Arg437, and Arg457) that yielded two peptides, one of which is identical to a PK-cleaved peptide. Glandular kallikrein is about 500-fold less active than is PK or tissue kallikrein, but it may play a physiologically important role in bradykinin release in seminal fluid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232657

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  9 in total

1.  The impact of hypoxemia on serum total and free prostate-specific antigen levels in patients with chronic obstructive pulmonary disease.

Authors:  Cengiz Ozge; Murat Bozlu; Eylem Sercan Ozgur; Mesut Tek; Ahmet Tunckiran; Necati Muslu; Ahmet Ilvan
Journal:  Med Oncol       Date:  2015-04-03       Impact factor: 3.064

2.  Male fertility defects in mice lacking the serine protease inhibitor protease nexin-1.

Authors:  V Murer; J F Spetz; U Hengst; L M Altrogge; A de Agostini; D Monard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells.

Authors:  Liza Barki-Harrington; Angela L Bookout; Gaofeng Wang; Maria E Lamb; L M Fredrik Leeb-Lundberg; Yehia Daaka
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

4.  Human seminal proteinase and prostate-specific antigen are the same protein.

Authors:  Abdul Waheed; Md Imtaiyaz Hassan; Robert L Van Etten; Faizan Ahmad
Journal:  J Biosci       Date:  2008-06       Impact factor: 1.826

5.  Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.

Authors:  Dinesh Srinivasan; Leah R Burbach; Donald V Daniels; Anthony P D W Ford; Anindya Bhattacharya
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 6.  Food components and contaminants as (anti)androgenic molecules.

Authors:  Daniele Marcoccia; Marco Pellegrini; Marco Fiocchetti; Stefano Lorenzetti; Maria Marino
Journal:  Genes Nutr       Date:  2017-02-16       Impact factor: 5.523

Review 7.  Sperm preparation for ART.

Authors:  Ralf R Henkel; Wolf-Bernhard Schill
Journal:  Reprod Biol Endocrinol       Date:  2003-11-14       Impact factor: 5.211

8.  Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application.

Authors:  Ruth A Fuhrman-Luck; Daniela Loessner; Judith A Clements
Journal:  EJIFCC       Date:  2014-10-24

9.  A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells via an Ectopic Olfactory Receptor.

Authors:  Tatjana Abaffy; James R Bain; Michael J Muehlbauer; Ivan Spasojevic; Shweta Lodha; Elisa Bruguera; Sara K O'Neal; So Young Kim; Hiroaki Matsunami
Journal:  Front Oncol       Date:  2018-05-28       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.